151 related articles for article (PubMed ID: 29380864)
1. The treatment outcomes and dose de-escalation of desloratadine up-dosing in chronic spontaneous urticaria.
Choonhakarn C; Chaowattanapanit S; Julanon N
Int J Dermatol; 2018 Apr; 57(4):423-427. PubMed ID: 29380864
[TBL] [Abstract][Full Text] [Related]
2. Critical temperature threshold measurement for cold urticaria: a randomized controlled trial of H(1) -antihistamine dose escalation.
Magerl M; Pisarevskaja D; Staubach P; Martus P; Church MK; Maurer M
Br J Dermatol; 2012 May; 166(5):1095-9. PubMed ID: 22242678
[TBL] [Abstract][Full Text] [Related]
3. Can on-demand non-sedating antihistamines improve urticaria symptoms? A double-blind, randomized, single-dose study.
Weller K; Ardelean E; Scholz E; Martus P; Zuberbier T; Maurer M
Acta Derm Venereol; 2013 Mar; 93(2):168-74. PubMed ID: 23053062
[TBL] [Abstract][Full Text] [Related]
4. Rupatadine is effective in the treatment of chronic spontaneous urticaria in children aged 2-11 years.
Potter P; Mitha E; Barkai L; Mezei G; Santamaría E; Izquierdo I; Maurer M
Pediatr Allergy Immunol; 2016 Feb; 27(1):55-61. PubMed ID: 26267219
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.
Staevska M; Popov TA; Kralimarkova T; Lazarova C; Kraeva S; Popova D; Church DS; Dimitrov V; Church MK
J Allergy Clin Immunol; 2010 Mar; 125(3):676-82. PubMed ID: 20226302
[TBL] [Abstract][Full Text] [Related]
6. Desloratadine for chronic idiopathic urticaria: a review of clinical efficacy.
DuBuske L
Am J Clin Dermatol; 2007; 8(5):271-83. PubMed ID: 17902729
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial.
Ortonne JP; Grob JJ; Auquier P; Dreyfus I
Am J Clin Dermatol; 2007; 8(1):37-42. PubMed ID: 17298105
[TBL] [Abstract][Full Text] [Related]
8. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study.
Nettis E; Colanardi MC; Paradiso MT; Ferrannini A
Clin Exp Allergy; 2004 Sep; 34(9):1401-7. PubMed ID: 15347373
[TBL] [Abstract][Full Text] [Related]
9. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.
Di Lorenzo G; Pacor ML; Mansueto P; Esposito Pellitteri M; Lo Bianco C; Ditta V; Martinelli N; Rini GB
J Allergy Clin Immunol; 2004 Sep; 114(3):619-25. PubMed ID: 15356567
[TBL] [Abstract][Full Text] [Related]
10. [The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial].
Kłos K; Kruszewski J; Kruszewski R; Sułek K
Pol Merkur Lekarski; 2006 Nov; 21(125):449-53. PubMed ID: 17345838
[TBL] [Abstract][Full Text] [Related]
11. High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study.
Siebenhaar F; Degener F; Zuberbier T; Martus P; Maurer M
J Allergy Clin Immunol; 2009 Mar; 123(3):672-9. PubMed ID: 19201016
[TBL] [Abstract][Full Text] [Related]
12. Influence of component 5a receptor 1 (C5AR1) -1330T/G polymorphism on nonsedating H1-antihistamines therapy in Chinese patients with chronic spontaneous urticaria.
Yan S; Chen W; Wen S; Zhu W; Guo A; Chen X; Zhang C; Chen M; Zhang J; Su J; Zhao Y; He Y; Liu Z; Zhou H; Zeng W; Li J; Chen X
J Dermatol Sci; 2014 Dec; 76(3):240-5. PubMed ID: 25455139
[TBL] [Abstract][Full Text] [Related]
13. Desloratadine in combination with montelukast suppresses the dermographometer challenge test papule, and is effective in the treatment of delayed pressure urticaria: a randomized, double-blind, placebo-controlled study.
Nettis E; Colanardi MC; Soccio AL; Ferrannini A; Vacca A
Br J Dermatol; 2006 Dec; 155(6):1279-82. PubMed ID: 17107402
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of desloratadine in chronic idiopathic urticaria in clinical practice: an observational study of 9246 patients.
Augustin M; Ehrle S
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):292-9. PubMed ID: 19438819
[TBL] [Abstract][Full Text] [Related]
15. Human H1 receptor (HRH1) gene polymorphism is associated with the severity of side effects after desloratadine treatment in Chinese patients with chronic spontaneous uticaria.
Li J; Chen W; Peng C; Zhu W; Liu Z; Zhang W; Su J; Li J; Chen X
Pharmacogenomics J; 2020 Feb; 20(1):87-93. PubMed ID: 31406237
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, active-controlled, parallel-group pilot study to compare the efficacy and sedative effects of desloratadine 5 mg with levocetirizine 5 mg in the treatment of chronic idiopathic urticaria.
Hong JB; Lee HC; Hu FC; Chu CY
J Am Acad Dermatol; 2010 Nov; 63(5):e100-2. PubMed ID: 20950731
[No Abstract] [Full Text] [Related]
17. Desloratadine 5 mg once daily improves the quality of life of patients with chronic idiopathic urticaria.
Lachapelle JM; Decroix J; Henrijean A; Roquet-Gravy PP; De Swerdt A; Boonen H; Lecuyer M; Suys E; Speelman G; Vastesaeger N
J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):288-92. PubMed ID: 16503889
[TBL] [Abstract][Full Text] [Related]
18. [Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial].
Kruszewski J; Kłos K; Sułek K
Pol Merkur Lekarski; 2006 Nov; 21(125):443-8. PubMed ID: 17345837
[TBL] [Abstract][Full Text] [Related]
19. CRP relevance in clinical assessment of chronic spontaneous urticaria Tunisian patients.
Maouia A; Youssef M; Leban N; Ben Chibani J; Helal AN; Kassab A
Cutan Ocul Toxicol; 2017 Dec; 36(4):387-392. PubMed ID: 28351163
[TBL] [Abstract][Full Text] [Related]
20. How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life.
Grob JJ; Auquier P; Dreyfus I; Ortonne JP
Allergy; 2009 Apr; 64(4):605-12. PubMed ID: 19133920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
